{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-038049","form_type":"8-K","ticker":"ELAB","cik":"0001840563","company_name":"PMGC Holdings Inc.","filed_at":"2025-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.068976+00:00","generated_at":"2026-05-23T01:03:52.775058+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"PMGC subsidiary Northstrive files four new patent applications for EL-22 and EL-32 programs","bullets":["Filing covers EL-22 in animals (App. 19/191,246) and EL-32 in obesity as monotherapy and with GLP-1 combos.","New patents also include EL-32 animal feed additive (App. 19/191,258) for muscle growth.","Northstrive's IP portfolio now totals 8 applications and 5 issued patents covering USA, Japan, Korea, China.","The filings aim to preserve muscle mass during obesity treatment and expand into animal health market."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-038049","json":"https://secwatch.observer/filing/0001213900-25-038049.json","markdown":"https://secwatch.observer/filing/0001213900-25-038049.md","text":"https://secwatch.observer/filing/0001213900-25-038049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840563/000121390025038049/0001213900-25-038049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840563/000121390025038049/ea0240193-8k_pmgc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T01:03:52.775058+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}